疤痕治療市場－全球產業規模、佔有率、趨勢、機會和預測，按產品、疤痕產品、最終用戶、地區和競爭細分，2020-2030 年

2024 年全球疤痕治療市場價值為 28.7 億美元，預計到 2030 年將達到 54.8 億美元，預測期內複合年成長率為 11.38%。市場成長主要得益於人們對美觀的認知不斷提高、道路和燒傷案件的增加以及引入先進治療設備的技術創新。 COVID-19 疫情進一步影響了市場，加速了遠距醫療在初次諮詢和後續護理中的應用，使疤痕治療變得更容易，而無需頻繁去醫院。根據美國整形外科醫師協會的數據，2022 年美國進行了約 50,930 例疤痕修復手術，凸顯了整容手術的上升趨勢。對美觀的追求導致人們擴大採用手術和非手術疤痕治療方案。

關鍵市場促進因素

道路交通事故和燒傷發生率上升

主要市場挑戰

高級疤痕治療費用高昂

主要市場趨勢

疤痕治療技術的進步

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球疤痕治療市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依產品（外用產品、雷射產品、注射劑、其他）
  • 依疤痕產品分類（萎縮性疤痕、肥厚性疤痕和蟹足腫、攣縮性疤痕、妊娠紋）
  • 按最終使用者（醫院和診所、門診護理中心、其他）
  • 按地區
  • 按公司分類（2024）
• 產品圖
  • 按產品
  • 按疤痕類型
  • 按最終用戶
  • 按地區

第6章：北美疤痕治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲疤痕治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太疤痕治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美疤痕治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東與非洲疤痕治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 近期發展
• 併購
• 產品發布

第 13 章：全球疤痕治療市場：SWOT 分析

第 14 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 15 章：競爭格局

• Smith & Nephew PLC
• Lumenis Ltd.
• Merz Pharmaceuticals, LLC
• Sonoma Pharmaceuticals, Inc.
• Cynosure, LLC
• CCA Industries, Inc.
• Newmedical Technology Inc.
• Molnlycke Health Care AB
• Perrigo Company plc
• Enaltus LLC

第 16 章：策略建議

第17章調查會社について,免責事項

The Global Scar Treatment Market was valued at USD 2.87 billion in 2024 and is projected to reach USD 5.48 billion by 2030, registering a CAGR of 11.38% during the forecast period. Market growth is primarily driven by increasing awareness around aesthetic appearance, rising cases of road and burn injuries, and technological innovations introducing advanced treatment devices. The COVID-19 pandemic further influenced the market by accelerating the use of telemedicine for initial consultations and follow-up care, making scar treatment more accessible without the need for frequent hospital visits. According to the American Society of Plastic Surgeons, approximately 50,930 scar revision surgeries were conducted in the U.S. in 2022, highlighting a rising trend in cosmetic procedures. The pursuit of aesthetic improvement is leading to increased adoption of both surgical and non-surgical scar treatment solutions.

Key Market Drivers

Rising Incidence of Road Accidents and Burn Injuries

The global scar treatment market is being largely influenced by the surge in road accidents and burn injuries. Data from the Population Reference Bureau indicates that about 50 million individuals suffer road accident injuries annually, many of whom require scar treatment. In the U.S., the CDC notes around 1.1 million burn injuries each year that require medical care, with roughly 50,000 cases necessitating hospitalization. These conditions frequently result in hypertrophic and keloid scars, causing both physical and emotional distress. This drives up demand for treatment options such as laser therapies, topical products, and surgeries. Additionally, government-backed reimbursement policies in countries like the U.S. further support access to these treatments, encouraging advancements and investment in the scar treatment industry.

Key Market Challenges

High Cost of Advanced Scar Treatment Procedures

A key obstacle in the scar treatment market is the considerable cost of advanced therapies, including laser treatments and surgical options. These high expenses can be prohibitive, especially in developing nations, where access to such services is limited. The situation is worsened by the general lack of insurance coverage for aesthetic treatments, forcing patients to pay out-of-pocket. This economic constraint limits market expansion and highlights the need for cost-effective treatment alternatives. Addressing this issue calls for coordinated action among stakeholders to explore affordable innovations and insurance solutions that make scar treatment more accessible.

Key Market Trends

Technological Advancements in Scar Treatment Modalities

Technological innovation is significantly enhancing scar treatment outcomes, improving both effectiveness and patient safety. Cutting-edge laser technologies such as Q-switched and fractional CO2 lasers are transforming the treatment of various scars. A notable advancement includes Cynosure's PicoSure Pro Device, launched in June 2022, aimed at treating acne scars, wrinkles, and pores. Simultaneously, the integration of telemedicine is reshaping how care is delivered. The rise of remote consultations and follow-ups-accelerated by the COVID-19 pandemic-has made scar treatment more convenient and accessible, especially for individuals in underserved or remote locations.

Key Market Players

• Smith & Nephew PLC
• Lumenis Ltd.
• Merz Pharmaceuticals, LLC
• Sonoma Pharmaceuticals, Inc.
• Cynosure, LLC
• CCA Industries, Inc.
• Newmedical Technology Inc.
• Molnlycke Health Care AB
• Perrigo Company plc
• Enaltus LLC

Report Scope:

In this report, the global scar treatment market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Scar Treatment Market, By Product:

• Topical Products
• Laser Products
• Injectables
• Others

Scar Treatment Market, By Scar Product:

• Atrophic Scars
• Hypertrophic & Keloid Scars
• Contracture Scars
• Stretch Marks

Scar Treatment Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Scar Treatment Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Scar Treatment Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Scar Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Topical Products, Laser Products, Injectables, Others)
  • 5.2.2. By Scar Product (Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, Stretch Marks)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Map
  • 5.3.1. By Product
  • 5.3.2. By Scar Type
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Scar Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Scar Type
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Scar Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Scar Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Scar Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Scar Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Scar Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Scar Type
      • 6.3.3.2.3. By End User

7. Europe Scar Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Scar Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Scar Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Scar Type
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Scar Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Scar Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Scar Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Scar Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Scar Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Scar Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Scar Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Scar Type
      • 7.3.5.2.3. By End User

8. Asia-Pacific Scar Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Scar Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Scar Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Scar Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Scar Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Scar Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Scar Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Scar Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Scar Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Scar Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Scar Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Scar Type
      • 8.3.5.2.3. By End User

9. South America Scar Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Scar Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Scar Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Scar Type
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Scar Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Scar Type
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Scar Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Scar Type
      • 9.3.3.2.3. By End User

10. Middle East and Africa Scar Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Scar Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Scar Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Scar Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Scar Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Scar Type
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Scar Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Scar Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Scar Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Smith & Nephew PLC
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Lumenis Ltd.
• 15.3. Merz Pharmaceuticals, LLC
• 15.4. Sonoma Pharmaceuticals, Inc.
• 15.5. Cynosure, LLC
• 15.6. CCA Industries, Inc.
• 15.7. Newmedical Technology Inc.
• 15.8. Molnlycke Health Care AB
• 15.9. Perrigo Company plc
• 15.10. Enaltus LLC

16. Strategic Recommendations

17. About Us & Disclaimer